assessment of operability of left to right shunts
TRANSCRIPT
INTRODUCTION
• PAH associated with CHD remains a problem
Mainly in pts in whom the LR shunt wasn’t diagnosed until childhood or even adulthood
In patients who didn’t have access to cardiovascular care and surgical management as infants, particularly in developing countries
• The 2009 ESC/ERS/ISHLT guidelines on the management of PAH subdivided PAH-CHD into 4 clinical groups:
(1) Eisenmenger syndrome
(2) PAH associated with systemic-to-pulmonary shunts
(3) PAH with small defects
(4) PAH after surgical repairEur Heart J 2009
Congenital Heart Disease (L-R shunts) and Pulmonary Hypertension
Maurice Beghetti, and Nazzareno Gali, J. Am. Coll. Cardiol. 2009;53;733-740
• The response of the pulmonary vasculature to high pulmonary blood flow is however not uniform and does not occur in a predictable fashion
What determines the development of pulmonary vascular obstructive disease?
Anatomy of defect
Associated conditions
Time
Pre vs. post tricuspidSize
Associated lesions: pulmonary venous
hypertension
Lungs and airways obstructionAltitudeSyndromes: Tri-21
Unknown influences
Genetic???
*
Large Fossa ovalis ASD
SV ASD
Unrestrictive VSD or PDA
TruncusTGA VSD/PDA
100%Li
kelih
oo
d o
f o
per
abili
ty
Age
Infancy Early childhood
Adolescence Adulthood
Defect vs. PVOD Risk
• Pre-tricuspid shunts: gradual increase in Qp as RV accommodates and enlarges – ASD, PAPVC, TAPVC*
• Post tricuspid shunts: Direct transmission of pressure head: VSD (systolic), PDA, AP-Window (systolic and diastolic)
• Pulmonary venous hypertension, associated mitral stenosis, other forms of LV inflow obstruction:
– May introduce a substantial element of reversibility
– May protect pulmonary vasculature from the effects of increased pulmonary blood flow???
Hypoxia elevates pulmonary vascular resistance • Diseases of pulmonary parenchyma• Airways (upper and lower)• Hypoventilation• High altitude
Time• The likelihood of development of PVOD increases with
time• The rate of increase in PVR varies depending on a
number of influences
Risk of development of PVOD: Other (unknown) influences
Remarkable individual variability
• ASD with severe PAH in a child
• VSD with shunt reversal in an infant
• Operable AP window in a teenager
• Operable large VSD in an adult
Prediction for an individual patient is sometimes quite challenging
Deciding operability of L to R shunts
• Clinical evaluation
• Chest X-ray and ECG
• Measurement of oxygen saturation
• Echocardiography
• Resting and post exercise ABG (PO2)
• MRI
• Cardiac catheterization
What principles govern decision on operability?
• Post tricuspid shunts: Generally operable if there is evidence of a significant shunt in the basal state irrespective of PA pressure
• Pre-tricuspid shunts: Pulmonary hypertension (anything more than mild) warrants concern especially if basal shunt is not obvious
Deciding operability: Principles
• Age is an important variable and benefit of doubt must be given to younger patients.
– E.g. a 1 year old with VSD and severe PAH where basal shunt is not obvious
• Lung, airway and ventilation issues can elevate PVR and confound assessment
• Pulmonary venous hypertension can result in reversible elevations in PVR
CLINICAL ASSESSMENT
• Serial assessment by multiple experienced clinicians improves the reliability of clinical examination as a tool in determining operability
• The presence of ‘clinical cyanosis’ or saturations <90% is a strong predictor of inoperability whereas the clear detection of a MDM on serial assessment strongly favoursoperability.
ABG
• The role of ABG measurement has not been adequately investigated
• A decline in arterial PO2 after exercise may suggest fixed PVR as the fall in SVR during exercise is not balanced by a corresponding fall in PVR
• Also allows assessment of respiratory function• The presence of ‘hypercarbia’ should alert the
clinician to look for restrictive or obstructive pulmonary disease as a contributory factor to the PHT
Interventricular and Transductal velocity by Doppler
• Clear understanding of the hemodynamics
• Comprehensive clinical assessment
• Influenced by the pulmonary artery and aortic pressures at the time of examination
• Proper alignment is essential
• Left parasternal view or high parasternal view for ductus; no ‘best’ view for VSD
• Record peak systolic and end diastolic gradients in PDA
CORRELATION BETWEEN PREOPERATIVE HEMODYNAMICS AND CLINICAL OUTCOMES
• The degree of individual variability makes it difficult to apply a single cut-off to determine operability
Lopes AA, O’Leary PW. Cardiol Young 2009
PVR Estimation by Cardiac Catheterization
Pulmonary artery mean
pressurePulmonary venous
mean pressure
Trans-pulmonary gradientPVR =
Pulmonary blood flow
Oxygen consumption
PVO2 content PA O2 Content
• Operability is defined on the basis of the likelihood of a favorable vs an unfavorable outcome.
• All the operability thresholds are defined to predict short-term success, which is immediate post-operative survival
• Although these are the best current proposals on assessing operability in CHD and PAH, there is no consensus as to whether vasoreactivity testing is accurate enough to discriminate between patients who will or will not have a good long term outcome
• Precise values of hemodynamic measures cannot be derived as individual patient factors such as cardiac lesion type and genetic predisposition may alter the hemodynamic testing or have an impact on outcome after surgical repair
• Hemodynamic assessment also aids in appropriate device selection
• The fenestrated ASD device can be considered in selected pts
• ASD or VSD device for patients with PDA and pulmonary hypertension instead of AmplatzerPDO
HOW USEFUL IS IT TO STUDY THE EFFECTS OF TEMPORARY SHUNT OCCLUSION?
• ‘‘Responders’’ - 25% fall in PA pressures on balloon occlusion or a 50% fall in the ratio between pulmonary and aortic diastolic pressures
• Pts with a high baseline PVR and low Qp/Qs ratio still may respond favorably to balloon occlusion and tolerate duct occlusion with normalization of PA pressures
• Immediate fall in pulmonary pressures may not translate into long term benefits
• The data available remains inconclusive and further clarification by studies with larger numbers is warranted.
LUNG BIOPSY
• Used to be routinely done• Now less frequently done in clinical practice• The results aren’t sufficiently reliable and not
without risk• Younger patients (<2 years of age) are often
operable in spite of seemingly advanced changes on lung biopsy
• Provides only one randomly selected area of the lung and does not represent a comprehensive evaluation of the nature and extent of lesions throughout the lungs
NOVEL MARKERS OF ASSESSING OPERABILITY
BIOMARKERS :
• ANP,BNP,Nt-pro-BNP,cardiac troponin T,uricacid,urinary prostaglandin metabolites,eNOSand dimethylarginines,ET-1 and ET-1:ET3 ratio,circulating VWF , cytokines (IL-1a, -2, -4, -6, -8, -10 and 12p70, TNF-b, MCP-1 and osteopontin),CRP,pim-1 & HbA1c
• Circulating endothelial cells and micro-RNAs
CONCLUSION
• Determining operability is important in patients with left to right shunts who present late
• A number of unresolved issues exist with currently available methods
• A comprehensive assessment that incorporates clinical evaluation, noninvasive investigations and in selected cases, cardiac catheterization is needed
• When in doubt, do not send patient for surgery • Efforts to evolve clear guidelines through careful
prospective studies need to be undertaken